Altria Shares Rise After FDA Approves Six Helix Nicotine Pouches

MT Newswires Live01:59

Altria (MO) shares rose more than 1% in recent trading Monday after six on! Plus nicotine pouches, made by its joint venture Helix Innovations, were authorized for marketing by the US Food and Drug Administration on Friday.

These are the first approvals under the FDA's pilot program to streamline nicotine pouch reviews, granted through the premarket tobacco product application pathway. The authorization covers mint, tobacco, and wintergreen flavors in 6 mg and 9 mg strengths, which can be legally sold to US adults aged 21 and over.

The FDA noted that the pouches contain fewer harmful chemicals than traditional smokeless tobacco and may benefit adults switching from cigarettes.

The pilot program's real-time communication allowed the FDA to complete reviews in record time. Altria said it will resume taking new retail and e-commerce orders in select states.

Price: 58.71, Change: +0.64, Percent Change: +1.10

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2593434786?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-23 01:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2593434786","market":"nz","top_or_hot":-1,"title":"Altria Shares Rise After FDA Approves Six Helix Nicotine Pouches","media":"MT Newswires Live","content":"<html><body><p> Altria (MO) shares rose more than 1% in recent trading Monday after six on! Plus nicotine pouches, made by its joint venture Helix Innovations, were authorized for marketing by the US Food and Drug Administration on Friday.</p><p>These are the first approvals under the FDA's pilot program to streamline nicotine pouch reviews, granted through the premarket tobacco product application pathway. The authorization covers mint, tobacco, and wintergreen flavors in 6 mg and 9 mg strengths, which can be legally sold to US adults aged 21 and over.</p><p>The FDA noted that the pouches contain fewer harmful chemicals than traditional smokeless tobacco and may benefit adults switching from cigarettes.</p><p>The pilot program's real-time communication allowed the FDA to complete reviews in record time. Altria said it will resume taking new retail and e-commerce orders in select states.</p><p>Price: 58.71, Change: +0.64, Percent Change: +1.10</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Altria Shares Rise After FDA Approves Six Helix Nicotine Pouches</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAltria Shares Rise After FDA Approves Six Helix Nicotine Pouches\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-23 01:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Altria (MO) shares rose more than 1% in recent trading Monday after six on! Plus nicotine pouches, made by its joint venture Helix Innovations, were authorized for marketing by the US Food and Drug Administration on Friday.</p><p>These are the first approvals under the FDA's pilot program to streamline nicotine pouch reviews, granted through the premarket tobacco product application pathway. The authorization covers mint, tobacco, and wintergreen flavors in 6 mg and 9 mg strengths, which can be legally sold to US adults aged 21 and over.</p><p>The FDA noted that the pouches contain fewer harmful chemicals than traditional smokeless tobacco and may benefit adults switching from cigarettes.</p><p>The pilot program's real-time communication allowed the FDA to complete reviews in record time. Altria said it will resume taking new retail and e-commerce orders in select states.</p><p>Price: 58.71, Change: +0.64, Percent Change: +1.10</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1066051225.USD","symbol_name":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AC\" (USD) ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2593434786","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2593434786","pubTimestamp":1766426360,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Altria  shares rose more than 1% in recent trading Monday after six on!Plus nicotine pouches, made by its joint venture Helix Innovations, were authorized for marketing by the US Food and Drug Administration on Friday.These are the first approvals under the FDA's pilot program to streamline nicotine pouch reviews, granted through the premarket tobacco product application pathway. The authorization covers mint, tobacco, and wintergreen flavors in 6 mg and 9 mg strengths, which can be legally sold to US adults aged 21 and over.The FDA noted that the pouches contain fewer harmful chemicals than traditional smokeless tobacco and may benefit adults switching from cigarettes.The pilot program's real-time communication allowed the FDA to complete reviews in record time. Altria said it will resume taking new retail and e-commerce orders in select states.Price: 58.71, Change: +0.64, Percent Change: +1.10","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1066051225.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AC\" (USD) ACC","BK4075":"烟草","BK4566":"资本集团","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","BK4588":"碎股","BK4585":"ETF&股票定投概念","MO":"奥驰亚","LU1066051811.HKD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (HKD) INC","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist"},"translate_title":"FDA批准六种Helix尼古丁袋后奥驰亚股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MO":1.5},"content_text":"Altria (MO) shares rose more than 1% in recent trading Monday after six on! Plus nicotine pouches, made by its joint venture Helix Innovations, were authorized for marketing by the US Food and Drug Administration on Friday.These are the first approvals under the FDA's pilot program to streamline nicotine pouch reviews, granted through the premarket tobacco product application pathway. The authorization covers mint, tobacco, and wintergreen flavors in 6 mg and 9 mg strengths, which can be legally sold to US adults aged 21 and over.The FDA noted that the pouches contain fewer harmful chemicals than traditional smokeless tobacco and may benefit adults switching from cigarettes.The pilot program's real-time communication allowed the FDA to complete reviews in record time. Altria said it will resume taking new retail and e-commerce orders in select states.Price: 58.71, Change: +0.64, Percent Change: +1.10","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2593434786","isCrawlerRequest":true}